A community-based Advanced Nurse Practitioner-led integrated oncology care model for adults receiving oral anticancer medication: A pilot study

Oral anti-cancer medications (OAMs) are being used increasingly within cancer care. OAMs offer the potential to improve patient convenience and increase hospital capacity. The clinical assessment for each cycle of OAMs requires specialist patient review often performed in the acute hospital. Consequently, any improvement in patient expediency or increased hospital capacity is not realised. This study aimed to develop and pilot the specialist assessment of patients receiving OAMs by an Advanced Nurse Practitioner (ANP) in a community setting. The primary aim of this pilot study was to assess the feasibility of a community-based ANP-led integrated oncology care model for adults receiving OAMs in Ireland who met the pre-specified eligibility criteria. The objectives were to determine the feasibility of a definitive trial of this intervention by measuring patient safety, acceptability to patients and staff and cost of the new model of care. This single-centre pilot study provided patient care (n = 37) to those receiving OAM therapies within a community setting for a 4-month period. Consent rate was high with no attrition other than for clinical reasons. There were 151 contacts with the sample during that time. Results demonstrated that the ANP-led intervention and new model for OAM care was safe, highly acceptable to patients and staff and that related healthcare costs could be captured. Based on the success of this pilot study the authors conclude that an ANP-led integrated oncology care model for adults receiving OAMs within a community setting is feasible, and a definitive trial is warranted. Trial Registration Trial registration: ISRCTN, ISRCTN10401455. Registered 30 November 2020, https://doi.org/10.1186/ISRCTN10401455